ID   HM-3 [Human mesothelia]
AC   CVCL_UZ40
SY   HM3
DR   Wikidata; Q94212653
RX   PubMed=9382953;
RX   PubMed=12077343;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Senescence: Senesces at 43 PDL (PubMed=12077343).
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
RX   PubMed=9382953; DOI=10.1089/hum.1997.8.16-1867;
RA   Murphy J.-E., Rheinwald J.G.;
RT   "Intraperitoneal injection of genetically modified, human mesothelial
RT   cells for systemic gene therapy.";
RL   Hum. Gene Ther. 8:1867-1879(1997).
//
RX   PubMed=12077343; DOI=10.1128/mcb.22.14.5157-5172.2002; PMCID=PMC139780;
RA   Rheinwald J.G., Hahn W.C., Ramsey M.R., Wu J.Y., Guo Z.-Y., Tsao H.,
RA   De Luca M., Catricala C., O'Toole K.M.;
RT   "A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence
RT   mechanism that limits replicative potential independent of telomere
RT   status.";
RL   Mol. Cell. Biol. 22:5157-5172(2002).
//